Kit for quantitatively detecting various beta-lactamase inhibitor residues and using method thereof
A technology for quantitative detection of lactamase, which is applied in the direction of material analysis by observing the impact on chemical indicators, and analysis by making materials undergo chemical reactions, can solve the problem of high-throughput, rapid detection, and inability to achieve 4 Simultaneous detection, high detection cost and other problems, to achieve the effect of wide screening range, low price and high detection sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] Embodiment 1 Preparation method 1 of the kit of the present invention
[0035] (1) For the configuration of the β-lactamase solution, use extended-spectrum β-lactamase and dilute it with a buffer to obtain a β-lactamase solution containing 50,000 units per milliliter.
[0036] (2) The configuration of the β-lactamase inhibitor standard solution, accurately weigh the sulbactam standard, dissolve it in buffer and adjust the volume to 10.00 mg / mL.
[0037] (3) The preparation of the substrate chromogenic stock solution, weighed nitrocefamin, dissolved in high quality dimethyl sulfoxide (DMSO) and diluted to 10 mg / mL.
[0038] (4) For the configuration of the buffer, a 0.5mol / L phosphate buffer solution with a pH of 7 is used.
Embodiment 2
[0039] Embodiment 2 The preparation method 2 of the kit of the present invention
[0040] (1) For the configuration of β-lactamase solution, use extended-spectrum β-lactamase, dilute it with a buffer containing 5% bovine serum albumin, 15% trehalose, 2% polyvinylpyrrolidone, and 5% proclin300 It is a β-lactamase solution containing 50,000 units per milliliter.
[0041] (2) The configuration of the β-lactamase inhibitor standard solution, accurately weigh the standard potassium clavulanate, dissolve it in a buffer containing 2% polyvinylpyrrolidone, and adjust the volume to 10.00 mg / mL.
[0042] (3) Preparation of substrate chromogenic stock solution: weigh nitrocefatin and dissolve in high-quality dimethyl sulfoxide (DMSO) containing 10% L-cysteine, 10% polyvinylpyrrolidone, and 10% glycerin Dilute to 10mg / mL.
Embodiment 3
[0043] Embodiment 3 Preparation method 3 of the kit of the present invention
[0044] (1) For the configuration of β-lactamase solution, use extended-spectrum β-lactamase, dilute it with a buffer containing 2% bovine serum albumin, 8% trehalose, 1% polyvinylpyrrolidone, and 2% proclin300 It is a β-lactamase solution containing 50,000 units per milliliter.
[0045] (2) The configuration of the β-lactamase inhibitor standard solution, accurately weigh the tazobactam standard, dissolve it in a buffer containing 1% polyvinylpyrrolidone, and adjust the volume to 10.00 mg / mL.
[0046] (3) Preparation of substrate chromogenic stock solution, weigh nitrocefatin and dissolve in high-quality dimethyl sulfoxide (DMSO) containing 5% L-cysteine, 5% polyvinylpyrrolidone, and 5% glycerin Dilute to 10mg / mL.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com